{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:46:53Z","timestamp":1778827613989,"version":"3.51.4"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.arr.2024.102209","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T06:47:39Z","timestamp":1706424459000},"page":"102209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy"],"prefix":"10.1016","volume":"95","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid S.","family":"Jabir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102209_bib1","doi-asserted-by":"crossref","unstructured":"Ali N.H., Al\u2010Kuraishy H.M., Al\u2010Gareeb A.I., Albuhadily A.K., Hamad R.S., Alexiou A., Papadakis M., Saad H.M., Batiha G.E. Role of brain renin\u2013angiotensin system in depression: A new perspective. CNS Neuroscience & Therapeutics. 2023 Nov 12.","DOI":"10.1111\/cns.14525"},{"issue":"4","key":"10.1016\/j.arr.2024.102209_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5455\/jice.20160815080732","article-title":"Effect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients","volume":"5","author":"Al-Kuraishy","year":"2016","journal-title":"J. Intercult. Ethnopharmacol."},{"issue":"03","key":"10.1016\/j.arr.2024.102209_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/0974-2727.208263","article-title":"Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: role of statins","volume":"9","author":"Al-Kuraishy","year":"2017","journal-title":"J. Lab. Physicians"},{"issue":"3","key":"10.1016\/j.arr.2024.102209_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/bbrj.bbrj_44_20","article-title":"Brain natriuretic peptide in patients with acute ischemic stroke: role of statins","volume":"4","author":"Al-Kuraishy","year":"2020","journal-title":"Biomed. Biotechnol. Res. J. (BBRJ)"},{"issue":"1","key":"10.1016\/j.arr.2024.102209_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/bc.bc_46_19","article-title":"Role of vinpocetine in ischemic stroke and poststroke outcomes: a critical review","volume":"6","author":"Al-Kuraishy","year":"2020","journal-title":"Brain Circ."},{"issue":"4","key":"10.1016\/j.arr.2024.102209_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4103\/IJCIIS.IJCIIS_7_20","article-title":"Statin therapy associated with decreased neuronal injury measured by serum S100\u03b2 levels in patients with acute ischemic stroke","volume":"11","author":"Al-Kuraishy","year":"2021","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"issue":"6","key":"10.1016\/j.arr.2024.102209_bib7","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.4103\/0028-3886.333482","article-title":"Statins therapy improves acute ischemic stroke in patients with cardio-metabolic disorders measured by lipoprotein-associated phospholipase A2 (Lp-PLA2): new focal point","volume":"69","author":"Al-Kuraishy","year":"2021","journal-title":"Neurol. India"},{"key":"10.1016\/j.arr.2024.102209_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fmed.2021.644295","article-title":"COVID-19 and risk of acute ischemic stroke and acute lung injury in patients with type ii diabetes mellitus: the anti-inflammatory role of metformin","volume":"8","author":"Al-Kuraishy","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.arr.2024.102209_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112193","article-title":"Arginine vasopressin and pathophysiology of COVID-19: an innovative perspective","volume":"143","author":"Al-Kuraishy","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.arr.2024.102209_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2174\/1874467214666210902115650","article-title":"Impact of sitagliptin on non-diabetic Covid-19 patients","volume":"15","author":"Al-Kuraishy","year":"2022","journal-title":"Curr. Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.arr.2024.102209_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1063","article-title":"Pros and cons for statins use and risk of Parkinson's disease: an updated perspective","volume":"11","author":"Al-Kuraishy","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"issue":"6","key":"10.1016\/j.arr.2024.102209_bib12","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jnr.25171","article-title":"SARS\u2010COV\u20102 infection and Parkinson's disease: possible links and perspectives","volume":"101","author":"Al-Kuraishy","year":"2023","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.arr.2024.102209_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102075","article-title":"The conceivable role of prolactin hormone in Parkinson disease: the same goal but with different ways","author":"Al-Kuraishy","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102209_bib14","first-page":"1","article-title":"New insights on the potential effect of vinpocetine in Parkinson\u2019s disease: one of the neglected warden and baffling topics","author":"Al-Kuraishy","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.arr.2024.102209_bib15","first-page":"1","article-title":"Parkinson\u2019s disease risk and hyperhomocysteinemia: the possible link","author":"Al-Kuraishy","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102209_bib16","first-page":"1","article-title":"Role of brain liver X receptor in Parkinson\u2019s disease: hidden treasure and emerging opportunities","author":"Alnaaim","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102209_bib17","first-page":"1","article-title":"Orexin pathway in Parkinson\u2019s disease: a review","author":"Alrouji","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.arr.2024.102209_bib18","first-page":"1","article-title":"Metformin role in Parkinson\u2019s disease: a double-sword effect","author":"Alrouji","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.arr.2024.102209_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.17784","article-title":"NF\u2010\u03baB\/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective","author":"Alrouji","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.arr.2024.102209_bib20","first-page":"1","article-title":"DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson\u2019s disease: a mutual relationship","author":"Alrouji","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.arr.2024.102209_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00180","article-title":"Progressive supranuclear palsy\u2014parkinsonism predominant (PSP-P)\u2014a clinical challenge at the boundaries of psp and Parkinson's disease (PD)","volume":"11","author":"Alster","year":"2020","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.arr.2024.102209_bib22","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/brainsci12101290","article-title":"Statins use in Alzheimer disease: bane or boon from frantic search and narrative review","volume":"12","author":"Alsubaie","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.arr.2024.102209_bib23","first-page":"259","article-title":"Statin-induced T-lymphocyte modulation and neuroprotection following experimental subarachnoid hemorrhage","author":"Ayer","year":"2013","journal-title":"Cereb. Vasospasm: Neurovasc. Events Subarachnoid Hemorrhage"},{"issue":"9","key":"10.1016\/j.arr.2024.102209_bib24","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/diagnostics12092051","article-title":"The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not?","volume":"12","author":"Babalghith","year":"2022","journal-title":"Diagnostics"},{"issue":"14","key":"10.1016\/j.arr.2024.102209_bib25","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.3390\/ijms241411295","article-title":"Endothelin-1 in health and disease","volume":"24","author":"Banecki","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.arr.2024.102209_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10787-022-01125-5","article-title":"SIRT1 pathway in Parkinson\u2019s disease: a faraway snapshot but so close","volume":"31","author":"Batiha","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.arr.2024.102209_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2023.100718","article-title":"Evaluation of rosuvastatin therapy on SIRT1 gene expression in patients with multiple sclerosis: a uncontrolled clinical trial","author":"Batoee","year":"2023","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.arr.2024.102209_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.01029","article-title":"Association between endothelial cell stabilizing medication and small vessel disease stroke: a case-control study","volume":"10","author":"Becker","year":"2019","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2024.102209_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000165343","article-title":"Vascular parkinsonism: a clinical review","volume":"61","author":"Benamer","year":"2008","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.arr.2024.102209_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/jnnp-2012-302618","article-title":"Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson\u2019s disease","volume":"84","author":"Benitez-Rivero","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102209_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrneurol.2011.21","article-title":"White matter lesions in Parkinson disease","volume":"7","author":"Bohnen","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102209_bib32","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/mds.10202","article-title":"Clinical correlates of the pathology underlying parkinsonism: a population perspective","volume":"17","author":"Bower","year":"2002","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.arr.2024.102209_bib33","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3892\/ijmm.2016.2506","article-title":"Atorvastatin ameliorates early brain injury after subarachnoid hemorrhage via inhibition of AQP4 expression in rabbits","volume":"37","author":"Chen","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.arr.2024.102209_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00401-009-0620-2","article-title":"Are there differences in cerebral white matter lesion burdens between Parkinson\u2019s disease patients with or without dementia?","volume":"119","author":"Choi","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.arr.2024.102209_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/brain\/52.1.23","article-title":"Arteriosclerotic parkinsonism","volume":"52","author":"Critchley","year":"1929","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102209_bib36","series-title":"Research Progress in Parkinson\u2019s Disease","first-page":"40","article-title":"Arteriosclerotic pseudo-parkinsonism","author":"Critchley","year":"1981"},{"issue":"10","key":"10.1016\/j.arr.2024.102209_bib37","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/mds.27812","article-title":"Parkinsonism and spastic paraplegia type 7: expanding the spectrum of mitochondrial Parkinsonism","volume":"34","author":"De la Casa-Fages","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102209_bib38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.parkreldis.2021.12.008","article-title":"What the VaP? The meaning of\" vascular parkinsonism\"","volume":"94","author":"Espay","year":"2022","journal-title":"Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.arr.2024.102209_bib39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000511121","article-title":"The effects of deep brain stimulation of the subthalamic nucleus on vascular endothelial growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in a rat model of Parkinson\u2019s disease","volume":"99","author":"Faust","year":"2021","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.arr.2024.102209_bib40","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/jnnp.49.9.1087","article-title":"A case of parkinsonism following striatal lacunar infarction (letter)","volume":"49","author":"Friedman","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102209_bib41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/NEN.0b013e3181d88e63","article-title":"Inverse relationship between cerebrovascular lesions and severity of lewy body pathology in patients with lewy body diseases","volume":"69","author":"Ghebremedhin","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102209_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-020-01682-w","article-title":"Assessing the effectiveness of statin therapy for alleviating cerebral small vessel disease progression in people\u2265 75 years of age","volume":"20","author":"Guo","year":"2020","journal-title":"BMC Geriatr."},{"issue":"7","key":"10.1016\/j.arr.2024.102209_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jalz.2019.06.001","article-title":"Preventing dementia by preventing stroke: the Berlin Manifesto","volume":"15","author":"Hachinski","year":"2019","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.arr.2024.102209_bib44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/ageing\/afp020","article-title":"Movement disorders after stroke","volume":"38","author":"Handley","year":"2009","journal-title":"Age Ageing"},{"key":"10.1016\/j.arr.2024.102209_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1750-3639.2012.00611.x","article-title":"Etiologies of parkinsonism in a century-long autopsy-based cohort","volume":"23","author":"Horvath","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2024.102209_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.arr.2024.102209_bib47","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/japtr.JAPTR_317_18","article-title":"Sulfonylurea and neuroprotection: the bright side of the moon","volume":"9","author":"Hussien","year":"2018","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"8","key":"10.1016\/j.arr.2024.102209_bib48","first-page":"133","article-title":"Statins and Covid-19: the neglected front of bidirectional effects","volume":"71","author":"Hussien","year":"2021","journal-title":"J. Pak. Med Assoc."},{"key":"10.1016\/j.arr.2024.102209_bib49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000110367","article-title":"Basal ganglia lacunes and parkinsonism","volume":"13","author":"Inzelberg","year":"1994","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.arr.2024.102209_bib50","first-page":"55","article-title":"The pathology of Parkinson\u2019s disease","volume":"86","author":"Jellinger","year":"2001","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.arr.2024.102209_bib51","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00401-003-0676-3","article-title":"Prevalence of cerebrovascular lesions in Parkinson\u2019s disease. A postmortem study","volume":"105","author":"Jellinger","year":"2003","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.arr.2024.102209_bib52","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jamda.2018.05.025","article-title":"Effect of low-dose statins and apolipoprotein E genotype on cerebral small vessel disease in older hypertensive patients: a subgroup analysis of a randomized clinical trial","volume":"19","author":"Ji","year":"2018","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"6","key":"10.1016\/j.arr.2024.102209_bib53","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/jioh.jioh_158_19","article-title":"Endothelin-1 is a surrogate biomarker link severe periodontitis and endothelial dysfunction in hypertensive patients: the potential nexus","volume":"11","author":"Kadhim","year":"2019","journal-title":"J. Int. Oral. Health"},{"key":"10.1016\/j.arr.2024.102209_bib54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mds.22937","article-title":"Differentiating vascular parkinsonism from idiopathic Parkinson\u2019s disease: a systematic review","volume":"25","author":"Kalra","year":"2010","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.arr.2024.102209_bib55","article-title":"Antioxidative activity of statins and HDL-PON1 association in lacunar ischemic stroke with and without white matter hyperintensity","volume":"17","author":"Kang","year":"2021","journal-title":"Signa Vitae"},{"issue":"7","key":"10.1016\/j.arr.2024.102209_bib56","article-title":"Effects of Statins on Renin\u2013Angiotensin System","volume":"8","author":"Kiaie","year":"2021","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.arr.2024.102209_bib57","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10072-017-2812-1","article-title":"MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson\u2019s disease","volume":"38","author":"Kim","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2024.102209_bib58","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrneurol.2015.61","article-title":"Vascular parkinsonism--characteristics, pathogenesis and treatment","volume":"11","author":"Korczyn","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102209_bib59","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","article-title":"Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways","volume":"60","author":"Koushki","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.arr.2024.102209_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.732820","article-title":"The \u201cneuro-glial-vascular\u201d unit: the role of glia in neurovascular unit formation and dysfunction","volume":"9","author":"Kugler","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.arr.2024.102209_bib61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.HYP.36.1.73-a","article-title":"Prevalence and risk factors of silent cerebral infarction in apparently normal adults","volume":"36","author":"Lee","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.arr.2024.102209_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.107987","article-title":"Serum Sirtuin1 level decreases in Parkinson's disease and Vascular parkinsonism: a prospective observational study","author":"Li","year":"2023","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.arr.2024.102209_bib63","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jss.2019.07.081","article-title":"Preinjury statins are associated with improved survival in patients with traumatic brain injury","volume":"245","author":"Lokhandwala","year":"2020","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.arr.2024.102209_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8067045","article-title":"Oxidative stress-related endothelial damage in vascular depression and vascular cognitive impairment: beneficial effects of aerobic physical exercise","volume":"2019","author":"Luca","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"12","key":"10.1016\/j.arr.2024.102209_bib65","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-019-1019-7","article-title":"Neuroimaging in vascular parkinsonism","volume":"19","author":"Ma","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"4","key":"10.1016\/j.arr.2024.102209_bib66","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/ggi.12167","article-title":"Serum levels of renin\u2013angiotensin system components in acute stroke patients","volume":"14","author":"Mogi","year":"2014","journal-title":"Geriatr. Gerontol. Int."},{"key":"10.1016\/j.arr.2024.102209_bib67","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s00415-009-5008-7","article-title":"Effects of statins on the progression of cerebral white matter lesion: post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study","volume":"256","author":"Mok","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2024.102209_bib68","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1523\/JNEUROSCI.1974-18.2019","article-title":"Impaired glymphatic transport in spontaneously hypertensive rats","volume":"39","author":"Mortensen","year":"2019","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.arr.2024.102209_bib69","article-title":"Aberrant neurogliovascular unit dynamics in cerebral small vessel disease: a rheological clue to vascular parkinsonism","volume":"13","author":"Nassir","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2024.102209_bib70","doi-asserted-by":"crossref","DOI":"10.4103\/aomd.aomd_31_22","article-title":"Dramatic improvement in freezing of gait with levodopa in a patient with vascular parkinsonism","author":"Onder","year":"2023","journal-title":"Ann. Mov. Disord."},{"issue":"2-3","key":"10.1016\/j.arr.2024.102209_bib71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000093235","article-title":"Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications","volume":"22","author":"Ovbiagele","year":"2006","journal-title":"Cerebrovasc. Dis."},{"issue":"1-2","key":"10.1016\/j.arr.2024.102209_bib72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-510X(03)00184-9","article-title":"Plasma levels of antioxidant vitamins C and E are decreased in vascular parkinsonism","volume":"215","author":"Paraskevas","year":"2003","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.arr.2024.102209_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64795-7","article-title":"Effect of statin therapy on plasma C-type Natriuretic Peptides and Endothelin-1 in males with and without symptomatic coronary artery disease","volume":"10","author":"Prickett","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.arr.2024.102209_bib74","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/japtr.JAPTR_65_19","article-title":"Effects of diabetic pharmacotherapy on prolactin hormone in patients with type 2 diabetes mellitus: Bane or Boon","volume":"10","author":"Rasheed","year":"2019","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.arr.2024.102209_bib75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000117089","article-title":"Parkinsonism in patients with lacunar infarcts of the basal ganglia","volume":"35","author":"Reider-Groswasser","year":"1995","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.arr.2024.102209_bib76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2017.12.030","article-title":"An updated diagnostic approach to subtype definition of vascular parkinsonism - recommendations from an expert working group","volume":"49","author":"Rektor","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102209_bib77","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.parkreldis.2019.02.046","article-title":"Microstructural changes of normal-appearing white matter in vascular parkinsonism","volume":"63","author":"Salsone","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102209_bib78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00019052-200402000-00009","article-title":"Vascular parkinsonism","volume":"17","author":"Sibon","year":"2004","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"10.1016\/j.arr.2024.102209_bib79","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/cells11081261","article-title":"GBA variants and Parkinson disease: mechanisms and treatments","volume":"11","author":"Smith","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.arr.2024.102209_bib80","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pneurobio.2017.08.007","article-title":"Lymphatic drainage system of the brain: a novel target for intervention of neurological diseases","volume":"163","author":"Sun","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2024.102209_bib81","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ageing\/afi025","article-title":"Vascular parkinsonism \u2013 an important cause of parkinsonism in older people","volume":"34","author":"Thanvi","year":"2005","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.arr.2024.102209_bib82","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/jnnp-2014-307867","article-title":"Clinicoradiological comparison between vascular parkinsonism and Parkinson\u2019s disease","volume":"86","author":"Vale","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102209_bib83","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/mds.26263","article-title":"Vascular parkinsonism: deconstructing a syndrome","volume":"30","author":"Vizcarra","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102209_bib84","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102209_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120014","article-title":"Parkinsonism in viral, paraneoplastic, and autoimmune diseases","volume":"433","author":"Xing","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2024.102209_bib86","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s13311-014-0270-5","article-title":"Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities","volume":"11","author":"Xiong","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"12","key":"10.1016\/j.arr.2024.102209_bib87","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014852","article-title":"Effect of statins on Parkinson's disease: a systematic review and meta-analysis","volume":"98","author":"Yan","year":"2019","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.arr.2024.102209_bib88","article-title":"Effects of rosuvastatin on neuronal apoptosis in cerebral ischemic stroke rats via Sirt1\/NF-kappa B signaling pathway","volume":"23","author":"Yan","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.arr.2024.102209_bib89","first-page":"34","article-title":"Plasma ApoA-1 and endothelin-1 levels changes in early Parkinson disease and its relationship with cognitive function and cerebral white matter structure change","author":"Yan","year":"2021","journal-title":"Pak. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.arr.2024.102209_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019333","article-title":"The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102209_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-020-02038-y","article-title":"Case Report of a pathologically confirmed vascular parkinsonism with early cognitive impairment and Behavioral disturbance","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Neurol."},{"key":"10.1016\/j.arr.2024.102209_bib92","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nic.2009.08.006","article-title":"The role of imaging in the diagnosis of vascular parkinsonism","volume":"20","author":"Zijlmans","year":"2010","journal-title":"Neuroimaging Clin. N. Am."},{"issue":"6","key":"10.1016\/j.arr.2024.102209_bib93","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","article-title":"Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis","volume":"19","author":"Zijlmans","year":"2004","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.arr.2024.102209_bib94","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","article-title":"Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis","volume":"19","author":"Zijlmans","year":"2004","journal-title":"Mov. Disord."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T23:57:20Z","timestamp":1744502240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":94,"alternative-id":["S1568163724000278"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102209","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102209"}}